2012 Summit Program

E-mail Print
2012_summit_logo_bluebox_-_copy
 
 

Monday November 26, 2012

05:00 PM

OPENING PLENARY
Welcome

Veronica Miller, Forum for Collaborative HIV Research
Kenneth H. Mayer, The Fenway Institute
John G. Bartlett, Johns Hopkins University School of Medicine

State of the Epidemics: Viral Hepatitis and HIV in the U.S.
Kevin Fenton, Centers for Disease Control and Prevention

HRSA and the National HIV/AIDS Strategy and Viral Hepatitis Action Plan
Sarah Linde-Feucht, Health Resources and Services Administration

KEYNOTE ADDRESS

Secretary Kathleen Sebelius, Department of Health and Human Services

 

 

 

07:00 PM

Dinner

Tuesday November 27, 2012

07:00 AM

Breakfast

08:00 AM

BREAKOUT SESSIONS
A. Routine and Expanded Testing:
 HIV Diagnostics and Testing
B. Prevention Models: Pre-Exposure Prophylaxis for HIV Prevention
C. Outcomes and Impact Evaluation: Surveillance, Observational Databases, and Cohorts
D. Access, Linkage and Retention in Care:
 Access to Care for Persons with HIV and Viral Hepatitis: Policy Forum

 
 
 
 

09:30 AM

Break

09:45 AM

BREAKOUT SESSIONS
A. Routine and Expanded Testing: 
HCV Diagnostics and Birth Cohort Testing
B. Prevention Models: Population Approaches to Prevention
C. Outcomes and Impact Evaluation: Clinical and cost-effectiveness research
D. Access, Linkage and Retention in Care:
 HCV Workforce Capacity: Models and the HCV Workforce

 
 
 
 

11:20 AM

AWARD PRESENTATION
2012 C. Everett Koop HIV/AIDS Public Health Leadership Award
Veronica Miller, Forum for Collaborative HIV Research
Anthony S. Fauci, National Institute of Allergy and Infectious Diseases
Representative Henry A. Waxman, U.S. House of Representatives

12:15 PM

Lunch

01:00 PM

AFTERNOON PLENARY
PANEL DISCUSSION: The Affordable Care Act, Opportunities and Challenges at the State and Local Level

Moderator:
Jeffrey S. Crowley, O'Neill Institute for National and Global Health Law, Georgetown Law
Panelists:
Steve Boswell, The Fenway Institute
Lynda Dee, AIDS Action Baltimore
Jennifer Kates, Kaiser Family Foundation
Donna Sweet, University of Kansas Medical Center

01:55 PM

BREAKOUT SESSIONS
A. Routine and Expanded Testing:
 Models for HIV and HCV Testing
Cross-Cutting Session: Viral Hepatitis and HIV Prevention, Diagnosis and Access to Care and Correctional Settings
C. Outcomes and Impact Evaluation: Outcomes and Epidemiology
D. Access, Linkage and Retention in Care:
 HIV Care and Treatment: Who are and Who will be the Providers?

 
 
 
 

03:15 PM

Break

03:30 PM

BREAKOUT SESSIONS
A. Routine and Expanded Testing:
 Testing Integration in the Primary Care Setting
B. Prevention Models: Focus on HIV Prevention for Most-At-Risk Populations
A. Routine and Expanded Testing: Policy Issues Affecting HIV and HCV Testing
D. Access, Linkage and Retention in Care:
 Care Models that Support Linkage and Retention in Care

 
 
 
 

05:00 PM

POSTER SESSION
Session A
Session B

 
 

07:00 PM

Dinner

08:00 PM

PERFORMANCE
THE MEDEA PROJECT: THEATER FOR INCARCERATED WOMEN

Wednesday November 28, 2012

07:00 AM

Breakfast

08:00 AM

RAPPORTEUR SESSION

09:10 AM

CLOSING PLENARY
Federal Response to the Viral Hepatitis and HIV Epidemics in the U.S.

Moderators: Henry Masur, National Institutes of Health Clinical Center, Kenneth H. Mayer, The Fenway Institute

The National HIV/AIDS Strategy at Two Years
Grant Colfax, Office of National AIDS Policy, The White House

Implementation of the Viral Hepatitis Action Plan
John Ward, Centers for Disease Control and Prevention

Monitoring the Impact of the NHAS and ACA on Improving HIV Care
Jennifer Kates, Kaiser Family Foundation

PANEL DISCUSSION: Federal Response
Grant Colfax, Office of National AIDS Policy, The White House
Jennifer Kates, Kaiser Family Foundation
John Ward, Centers for Disease Control and Prevention

 
 
 
 

10:15 AM

Break

10:30 AM

Treatment & Prevention: New Research Going Forward
Moderators: John G. Bartlett, Johns Hopkins University School of Medicine, Veronica Miller, Forum for Collaborative HIV Research

A New Look at Treatment as Prevention
Myron Cohen, University of North Carolina School of Medicine

Behavioral Economics: A Role in HIV and Viral Hepatitis Treatment and Prevention?
Kevin Volpp, Perelman School of Medicine, University of Pennsylvania

PANEL DISCUSSION:

Myron Cohen, University of North Carolina School of Medicine
Naresh Chand, National Institute on Drug Abuse
Henry Masur, National Institutes of Health Clinical Center
Daniel Raymond, Harm Reduction Coalition
David Thomas, Johns Hopkins Center for Global Health
Kevin Volpp, Perelman School of Medicine, University of Pennsylvania

 
 
 

11:45 AM

Closing Remarks
Kenneth H. Mayer, The Fenway Institute
John G. Bartlett, Johns Hopkins University School of Medicine
Veronica Miller, Forum for Collaborative HIV Research